Country

Merz Products Recognized as Best-In-Class by NewBeauty, THE European Aesthetic Guide and InStyle Magazine

Ultherapy®, Radiesse®, Cellfina® and Neocutis® receive prestigious award

Merz announced today that Ultherapy®, Radiesse® and Cellfina® have been named the best “In-Office Treatments” by NewBeauty Magazine. In addition, Cellfina® was recognized as the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide. Neocutis® Lumière® and Lumière® Riche were named “Best Beauty Buys” by InStyle Magazine.

“These awards demonstrate the high level of patient satisfaction with Merz’s portfolio of treatments and products,” said Bob Rhatigan, CEO of Merz North America. “With our award-winning offerings, physicians are able to address their patients’ needs with trusted technologies that have proven results for the face and body.”

This is the fifth consecutive year Ultherapy® has received a NewBeauty award and was named the “Tried-and-True Skin Tightener” in 2018 for its ultrasound technology that lifts and tightens skin. Cellfina® won for the second year in a row and was named the “Ultimate Cellulite Fighter” for being effective for up to three years. For the first time, Radiesse® was named the “Quick Fix For Better-Looking Hands” for being the only filler FDA-approved to correct lost volume in hands. NewBeauty Magazine readers, as well as renowned beauty experts and editors, made their votes count in the magazine’s eighth annual Beauty Choice Awards, selecting several Merz products from thousands of submissions and hundreds of nominations. The Beauty Choice Awards recognize the industry’s best products.

In addition, Cellfina® was named the “Best Non-Surgical Body Shaping Device” by THE European Aesthetic Guide as part of its second annual industry awards. THE Aesthetic Industry Awards celebrate innovative, cutting-edge technologies, techniques and practices at the forefront of the aesthetic space. Cellfina® was recognized as the only U.S. FDA-cleared and EU CE Mark-certified cellulite treatment that is a minimally invasive, one-time procedure clinically proven to improve the appearance of cellulite for at least three years – the longest duration for a cellulite treatment that targets the primary structural cause of cellulite.

InStyle Magazine named Neocutis® Lumière® and Lumière® Riche “Best Beauty Buys” in 2018, marking the nineteenth time Neocutis® has been awarded the title since 2009. Lumière® received two awards this year for “Best Eye Cream” and “Best Anti-Aging Eye Cream,” and Lumière® Riche won the award for “Best Dry Skin Eye Cream.” Neocutis Lumière® has been honored as an InStyle “Best Beauty Buy” 10 years in a row. This is the second time Lumière® Riche has been honored as the best eye cream for dry skin.

For full product and safety information, including possible mild side effects of Ultherapy, Cellfina® and Radiesse®, visit www.ultherapy.com/IFU, www.cellfina.com/IFU and www.radiesse.com/instructions-for-use-and-patient-guide, respectively.

For additional information on Neocutis®, or to find an authorized Neocutis® skincare provider near you, visit www.neocutis.com.

About Merz North America, Inc.
Merz North America, Inc. is a specialty healthcare company dedicated to the development and marketing of innovative quality products for physicians and patients across the United States and Canada. Merz products are distributed through two divisions, Aesthetics and Neurosciences, and are developed with the goal of improving patients’ health and quality of life by delivering therapies that bring about real progress. Privately-held, Merz North America is headquartered in Raleigh, North Carolina. To learn more about Merz North America, Inc., please visit www.merzusa.com.

Merz Pharma Group
With approximately 3,000 employees and 34 subsidiaries worldwide, Merz is a global leader in Aesthetics and Neurotoxins. Privately held for more than 100 years, the company is distinguished by its in-house research and development, solid financial strength and continuous growth. Complementing its unique portfolio of products for minimally invasive and non-invasive skin rejuvenation and tightening, Merz also develops neurotoxin therapy for the treatment of movement disorders. Skincare products and a range of OTC medicines are also included in offerings from the company, which is headquartered in Frankfurt, Germany. In fiscal year 2016/17, the Merz Pharma Group generated revenue of EUR 1,023.2 million. More information is available at www.merz.com.

Press Contact

Merz North America

Emily Browder
Corporate Communications

 

Phone: +1 919.582.8114